Systematic screening has identified numerous circulating molecules that control differentiation and thermogenic capacity in both brown and beige adipocytes, including irisin, FGF21, BMP8, NRG-4, and IL-6, establishing potential therapeutic targets for treating metabolic disorder (61). This evidence concerns the gene FNDC5 and Other metabolic disease.